Peptide Supplements Under Scrutiny: FDA Panel to Weigh Easing Access Amid Safety Concerns A growing trend in the health and wellness industry has raised concerns among medical professionals, as supplements containing peptides have gained popularity among consumers. Despite a lack of robust scientific evidence supporting their efficacy and safety, the FDA is set to convene a panel later this month to discuss potential changes to regulations governing access to these supplements. Critics argue that the lack of rigorous research on peptides makes it difficult to ensure their safety and effectiveness, while proponents claim that they offer promising benefits for various health conditions. As the FDA panel prepares to weigh in on the matter, questions remain about the potential risks and benefits of peptide supplements.
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
